1. Home
  2. NVO vs WFC Comparison

NVO vs WFC Comparison

Compare NVO & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • WFC
  • Stock Information
  • Founded
  • NVO 1923
  • WFC 1852
  • Country
  • NVO Denmark
  • WFC United States
  • Employees
  • NVO N/A
  • WFC 212804
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • WFC Major Banks
  • Sector
  • NVO Health Care
  • WFC Finance
  • Exchange
  • NVO Nasdaq
  • WFC Nasdaq
  • Market Cap
  • NVO 278.0B
  • WFC 261.0B
  • IPO Year
  • NVO N/A
  • WFC N/A
  • Fundamental
  • Price
  • NVO $55.81
  • WFC $81.33
  • Analyst Decision
  • NVO Buy
  • WFC Buy
  • Analyst Count
  • NVO 7
  • WFC 15
  • Target Price
  • NVO $98.00
  • WFC $82.25
  • AVG Volume (30 Days)
  • NVO 14.9M
  • WFC 13.7M
  • Earning Date
  • NVO 11-05-2025
  • WFC 10-14-2025
  • Dividend Yield
  • NVO 2.24%
  • WFC 2.21%
  • EPS Growth
  • NVO 24.25
  • WFC 19.49
  • EPS
  • NVO 3.93
  • WFC 5.82
  • Revenue
  • NVO $49,108,936,497.00
  • WFC $77,618,000,000.00
  • Revenue This Year
  • NVO $10.01
  • WFC $7.81
  • Revenue Next Year
  • NVO $9.93
  • WFC $4.68
  • P/E Ratio
  • NVO $13.90
  • WFC $13.98
  • Revenue Growth
  • NVO 20.91
  • WFC N/A
  • 52 Week Low
  • NVO $45.05
  • WFC $50.22
  • 52 Week High
  • NVO $138.22
  • WFC $84.83
  • Technical
  • Relative Strength Index (RSI)
  • NVO 51.25
  • WFC 54.50
  • Support Level
  • NVO $53.55
  • WFC $79.78
  • Resistance Level
  • NVO $55.24
  • WFC $81.46
  • Average True Range (ATR)
  • NVO 1.13
  • WFC 1.63
  • MACD
  • NVO 0.24
  • WFC 0.07
  • Stochastic Oscillator
  • NVO 69.52
  • WFC 59.25

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About WFC Wells Fargo & Company

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US.

Share on Social Networks: